Cartalax 20 mg

Technical Details

Dosage & Usage Guidelines

Researchers use Cartalax in preclinical studies investigating:

• Cartilage regeneration after injury or degradation
• Arthritis and osteoarthritis mitigation
• Joint stiffness and inflammation reduction
• Post-surgical or post-injury soft tissue recovery

Cartalax is especially popular in experimental models involving athletes, aging populations, or animals exposed to joint degradation under stress. It's also been explored alongside regenerative peptides like BPC-157 and GHK-CU for broader musculoskeletal support.

Suggested Experimental Use

• Dose: 10–20 mg per day
• Route: Subcutaneous injection
• Cycle: 10–30 days depending on joint injury severity

Stacking Options

To optimize recovery and maximize tissue support, Cartalax is often stacked with:

• BPC-157 – for tendon and ligament healing
• ARA-290 – anti-inflammatory and nerve-supporting peptide
• GHK-CU – for collagen repair and oxidative stress modulation

Safety & Legality

Cartalax is well tolerated in research models. It is non-hormonal, non-toxic to the liver, does not cause acne, water retention, or interfere with blood pressure. However, it is strictly intended for research purposes. It is not FDA-approved for human consumption and should be handled in accordance with standard lab safety procedures.

Learn More

To track regulatory developments or clinical research into peptide bioregulators like Cartalax, visit the ClinicalTrials.gov database.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions